Skip to content

Agalsidase beta

Fabrazyme (agalsidase beta) is an enzyme pharmaceutical. Agalsidase beta was first approved as Fabrazyme on 2001-08-03. It is used to treat fabry disease in the USA. It has been approved in Europe to treat fabry disease.
Trade Name Fabrazyme
Common Name Agalsidase beta
Indication fabry disease
Drug Class Enzymes
Agalsidase beta
Get full access now